Undetectable CSF hypocretin-1 in "Hashimoto's encephalopathy" associated with coma

Neurology

Volumn 62, Issue 10, 2004, Pages 1909-

  Castillo, Pablo R ^a,c   Mignot, Emmanuel ^a,d   Woodruff, Bryan K ^a   Boeve, Bradley F ^a,b,e  

^a MAYO CLINIC   (United States)

^b Mayo Clinic ^*

^c UNIVERSITY OF MINNESOTA   (United States)

^d Stanford California and Cofounder   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; OREXIN A; PREDNISONE;

AGED; ARTICLE; AUTOIMMUNE DISEASE; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; COMA; DISEASE ASSOCIATION; HASHIMOTO DISEASE; HASHIMOTO ENCEPHALOPATHY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SOMNOLENCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 2442718925     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000125284.19326.80     Document Type: Article

References (7)

1. Castillo PR, Boeve BF, Caselli RJ, et al. Steroid-responsive encephalopathy associated with thyroid autoimmunity: clinical and laboratory findings. Neurology 2002;58:A248.
2. Schauble B, Castillo PR, Boeve BF, Westmoreland BF. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 2003;114:32-37.
3. Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high antithyroid antibody titers-report of 5 cases. Neurology 1991;41:228-233.
4. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003;60:164-171.
5. Lin L, Hungs M, Mignot E. Narcolepsy and the HLA region. J Neuroimmunol 2001;117:9-20.
6. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-1562.
7. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 2002;5(suppl): 1071-1075.